289 related articles for article (PubMed ID: 29475007)
1. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
[TBL] [Abstract][Full Text] [Related]
2. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
3. Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein.
Prueksaritanont T; Meng Y; Ma B; Leppert P; Hochman J; Tang C; Perkins J; Zrada M; Meissner R; Duggan ME; Lin JH
Xenobiotica; 2002 Mar; 32(3):207-20. PubMed ID: 11958560
[TBL] [Abstract][Full Text] [Related]
4. Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver.
Delle Monache MD; Gigliozzi A; Benedetti A; Marucci L; Bini A; Francia C; Papa E; Di Cosimo E; Fraioli F; Jezequel AM; Alvaro D
Dig Dis Sci; 1999 Nov; 44(11):2196-204. PubMed ID: 10573362
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
6. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
[TBL] [Abstract][Full Text] [Related]
7. Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition.
Bedada SK; Yellu NR; Neerati P
Pharmacol Rep; 2016 Apr; 68(2):338-43. PubMed ID: 26922536
[TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
[TBL] [Abstract][Full Text] [Related]
9. Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor.
Huang K; Hu J; Li X; Li Y
Drug Metab Pharmacokinet; 2012; 27(5):486-94. PubMed ID: 22447116
[TBL] [Abstract][Full Text] [Related]
10. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
[TBL] [Abstract][Full Text] [Related]
11. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.
Yang Z; Gao S; Wang J; Yin T; Teng Y; Wu B; You M; Jiang Z; Hu M
Drug Metab Dispos; 2011 Oct; 39(10):1866-72. PubMed ID: 21757611
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine.
Ni L; Yu X; Yu Q; Chen X; Jia L
Drug Metab Lett; 2008 Aug; 2(3):163-8. PubMed ID: 19356088
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of P-glycoprotein mediated in vitro loperamide biliary excretion with sandwich-cultured rat hepatocytes model].
Shen GL; Zhuang XM; Yuan M; Sun HX; Li H
Yao Xue Xue Bao; 2012 Apr; 47(4):459-65. PubMed ID: 22799027
[TBL] [Abstract][Full Text] [Related]
15. Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.
Arimori K; Kuroki N; Hidaka M; Iwakiri T; Yamsaki K; Okumura M; Ono H; Takamura N; Kikuchi M; Nakano M
Pharm Res; 2003 Jun; 20(6):910-7. PubMed ID: 12817897
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro.
Adachi Y; Suzuki H; Sugiyama Y
Pharm Res; 2003 Aug; 20(8):1163-9. PubMed ID: 12948013
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
[TBL] [Abstract][Full Text] [Related]
19. In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay.
Rabba AK; Si L; Xue K; Li M; Li G
J Pharm Pharm Sci; 2011; 14(2):138-47. PubMed ID: 21733405
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
Shang H; Sun Y; Wang Z; Zhou Y; Yang H; Ci X; Cui T; Xia Y; Gu Y; Liao M; Li Q; Si D; Liu C
J Ethnopharmacol; 2022 May; 289():115006. PubMed ID: 35051604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
